RESUMEN
The diagnosis of vascular anomalies remains challenging due to significant clinical heterogeneity and uncertain etiology. Evaluation using biopsy and/or genetic testing for somatic variants is invasive, expensive, and prone to sampling error. There is great need for noninvasive and easily measured blood laboratory biomarkers that can aid not only in diagnosis, but also management of treatments for vascular anomalies. Angiopoietin-2, a circulating blood angiogenic factor, is highly elevated in patients with kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon and kaposiform lymphangiomatosis. Here, we describe our clinical experience using serum angiopoietin-2 as a biomarker for diagnosis and monitoring response to treatment.
Asunto(s)
Angiopoyetina 2 , Malformaciones Vasculares , Humanos , Angiopoyetina 2/sangre , Biomarcadores/sangre , Hemangioendotelioma/sangre , Hemangioendotelioma/diagnóstico , Hemangioendotelioma/terapia , Síndrome de Kasabach-Merritt/sangre , Síndrome de Kasabach-Merritt/diagnóstico , Síndrome de Kasabach-Merritt/terapia , Malformaciones Vasculares/sangre , Malformaciones Vasculares/diagnóstico , Malformaciones Vasculares/terapiaRESUMEN
Pexacerfont is a corticotrophin-releasing factor subtype 1 receptor (CRF-1) antagonist developed for potential treatment of anxiety and stress-related disorders. In male rats, pexacerfont caused hepatic enzyme induction leading to increased thyroxine (T4) clearance. When administered to pregnant rats on gestation day 6 to 15, pexacerfont at 300 mg/kg/day (30× mean AUC in humans at 100 mg/day) produced similar effects on thyroid homeostasis with serum T4 and thyroid-stimulating hormone levels that were 0.3-0.5× and 3.3-3.7× of controls, respectively. At this dose, fetuses of pexacerfont-treated dams presented findings associated with maternal hypothyroidism including growth retardation and increased skeletal alterations. Additionally, there were unexpected great vessel malformations that were mostly derived from the 4th pharyngeal arch artery in 5 (4.3%) fetuses from 3 (15.8%) litters. The etiology was unclear whether the vascular malformations were related to insufficient thyroid hormones or another mechanism. To better understand this relationship, pregnant rats were implanted with a subcutaneous L-thyroxine pellet designed to provide a sustained release of T4 throughout organogenesis in rat embryos (GD 6 to 15; the dosing period of pexacerfont). T4 supplementation produced a near euthyroid state in pexacerfont-treated dams and completely prevented the fetal vascular malformations. These results suggest maternal T4 levels during organogenesis may have a role in great vessel morphogenesis associated with patterning and/or regression of pharyngeal arch arteries. Although previous clinical reports have speculated a potential relationship between thyroid hormone homeostasis and early cardiovascular development, this is the first report to experimentally demonstrate this relationship in great vessel morphogenesis.
Asunto(s)
Aorta/efectos de los fármacos , Antagonistas de Hormonas/toxicidad , Pirazoles/toxicidad , Tiroxina/farmacología , Triazinas/toxicidad , Malformaciones Vasculares/prevención & control , Animales , Aorta/anomalías , Implantes de Medicamentos , Femenino , Edad Gestacional , Hipotiroidismo/sangre , Hipotiroidismo/inducido químicamente , Hipotiroidismo/prevención & control , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Exposición Materna , Morfogénesis , Organogénesis , Embarazo , Complicaciones del Embarazo/sangre , Complicaciones del Embarazo/inducido químicamente , Complicaciones del Embarazo/prevención & control , Ratas , Tirotropina/sangre , Tiroxina/administración & dosificación , Tiroxina/sangre , Toxicocinética , Malformaciones Vasculares/sangre , Malformaciones Vasculares/inducido químicamenteRESUMEN
BACKGROUND: Patients with univentricular heart disease may undergo a superior cavopulmonary anastomosis, an operative intervention that raises cerebral venous pressure and impedance to cerebral venous return. The ability of infantile cerebral autoregulation to compensate for this is not well understood. MATERIALS AND METHODS: We identified all patients undergoing a superior cavopulmonary anastomosis (cases) and compared metrics of cerebral oxygenation upon admission to the ICU with patients following repair of tetralogy of Fallot or arterial switch operation (controls). The primary endpoint was cerebral venous oxyhaemoglobin saturation measured from an internal jugular venous catheter. Other predictor variables included case-control assignment, age, weight, sex, ischemic times, arterial oxyhaemoglobin saturation, mean arterial blood pressure, and superior caval pressure. RESULTS: A total of 151 cases and 350 controls were identified. The first post-operative cerebral venous oxyhaemoglobin saturation was significantly lower following superior cavopulmonary anastomosis than in controls (44 ± 12 versus 59 ± 15%, p < 0.001), as was arterial oxyhaemoglobin saturation (81 ± 9 versus 98 ± 5%, p < 0.001). Cerebral venous oxyhaemoglobin saturation correlated poorly with superior caval pressure in both groups. When estimated by linear mixed effects model, arterial oxyhaemoglobin saturation was the primary determinant of central venous oxyhaemoglobin saturation in both groups (ß = 0.79, p = 3 × 10-14); for every 1% point increase in arterial oxyhaemoglobin saturation, there was a 0.79% point increase in venous oxyhaemoglobin saturation. In this model, no other predictors were significant, including superior caval pressure and case-control assignment. CONCLUSION: Cerebral autoregulation appears to remain intact despite acute imposition of cerebral venous hypertension following superior cavopulmonary anastomosis. Following superior cavopulmonary anastomosis, cerebral venous oxyhaemoglobin saturation is primarily determined by arterial oxyhaemoglobin saturation.
Asunto(s)
Presión Sanguínea/fisiología , Circulación Cerebrovascular/fisiología , Puente Cardíaco Derecho/métodos , Oxígeno/sangre , Venas Pulmonares/cirugía , Malformaciones Vasculares/cirugía , Vena Cava Superior/cirugía , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Masculino , Consumo de Oxígeno , Venas Pulmonares/diagnóstico por imagen , Estudios Retrospectivos , Malformaciones Vasculares/sangre , Malformaciones Vasculares/fisiopatología , Vena Cava Superior/diagnóstico por imagenRESUMEN
BACKGROUND/OBJECTIVES: Stagnant blood flow present in slow-flow vascular malformations can lead to localized intravascular coagulopathy (LIC), measured by elevated D-dimer levels, low fibrinogen, and/or thrombocytopenia. LIC can lead to localized thrombosis and/or bleeding, resulting in pain, swelling, and functional limitations. Patients with complex vascular malformations treated with sirolimus show clinical improvement in these symptoms. We hypothesized that the clinical benefits of sirolimus may correlate with improvements in coexisting LIC. DESIGN/METHODS: A retrospective chart review was performed, including D-dimer, fibrinogen, and platelet count, in patients with slow-flow vascular malformations treated with sirolimus. Laboratory values were assessed at three time points (presirolimus, 1-3 months postsirolimus, and last clinic visit). Clinical response, as defined by decreased pain and swelling, was extracted from the record. RESULTS: Thirty-five patients at our vascular anomalies center had been prescribed sirolimus between 2014 and 2017. Fifteen patients (12 combined slow-flow vascular malformations and three pure venous malformations) remained after excluding patients that did not have adequate records or a venous component to their vascular malformation. Patients who did not adhere to the treatment were also excluded. All 15 had elevated D-dimer levels prior to treatment and there was a statistically significant decrease in D-dimer levels following treatment with sirolimus. Symptomatic improvement of pain and swelling was reported after 3 months of starting sirolimus in 13/15 patients. CONCLUSION: This study suggests that sirolimus improves coagulopathy in slow-flow vascular malformations, as evidenced by reduced D-dimer levels. Improvement in LIC symptoms also correlates with sirolimus-corrected coagulopathy.
Asunto(s)
Trastornos de la Coagulación Sanguínea/sangre , Trastornos de la Coagulación Sanguínea/tratamiento farmacológico , Sirolimus/uso terapéutico , Malformaciones Vasculares/sangre , Adolescente , Adulto , Trastornos de la Coagulación Sanguínea/etiología , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Estudios Retrospectivos , Malformaciones Vasculares/complicaciones , Adulto JovenRESUMEN
Proper vascular function is important for well-being of mother and growing fetus. VEGFTOTAL, and VEGF165b levels and its vascular endothelial complications in gestational diabetes mellitus (GDM) together with the association of inflammation and advanced glycation end products (AGEs) are less studied. VEGF165b/VEGFTOTAL (VEGF RATIO) in GDM pregnant women was investigated in this study. Plasma VEGFTOTAL was lower in GDM (17.68 ± 1.30 pg/mL) compared to non-GDM (25.69 ± 1.40 pg/mL). VEGF165b, ICAM-1, and AGEs were higher in GDM (9.9 ± 1.4 pg/mL, 201.04 ± 7.85 µg/mL, and 10.40 ± 0.98 µg/mL, respectively) and lower in non-GDM (6.47 ± 0.70 pg/mL, 174.1 ± 7.11 µg/mL, and 4.71 ± 0.39 µg/mL, respectively). Compared to non GDM (0.25 ± 0.02), VEGF RATIO was higher in GDM (0.45 ± 0.04) and correlated with -ICAM-1 (r = 0.375, p < .001) and AGEs (r = 0.199, p < .05). Tertile stratification of VEGF RATIO implied that frequency of GDM increases with increasing tertiles of VEGF RATIO (p for trend <.001). Association of VEGF RATIO with GDM was significant even after adjusting for AGEs (OR = 1.279, CI = 1.118-1.462, p < .0010) but it lost its significance when adjusted for ICAM-1 (OR = 1.006, CI = 0.995-1.017, p = .308). VEGF RATIO plays an important role in GDM in association with vascular inflammation.
Asunto(s)
Diabetes Gestacional/sangre , Factor A de Crecimiento Endotelial Vascular/sangre , Adulto , Glucemia/análisis , Glucemia/metabolismo , Estudios de Casos y Controles , Femenino , Productos Finales de Glicación Avanzada/sangre , Humanos , Molécula 1 de Adhesión Intercelular/sangre , Fragmentos de Péptidos/sangre , Embarazo , Complicaciones Cardiovasculares del Embarazo/sangre , Isoformas de Proteínas/sangre , Isoformas de Proteínas/química , Factor A de Crecimiento Endotelial Vascular/química , Malformaciones Vasculares/sangre , Malformaciones Vasculares/complicaciones , Adulto JovenRESUMEN
Importance: Differential diagnosis of congenital vascular anomalies is challenging, and misdiagnosis is frequent. Vascular malformations are considered one of the most difficult vascular diseases to treat. A new imaging approach that visualizes anatomical features and quantitatively assesses molecular biomarkers noninvasively would aid diagnosis and monitoring of treatment response of vascular malformations. Objective: To evaluate multispectral optoacoustic tomography (MSOT) for noninvasive assessment of molecular biomarkers for diagnosis and therapeutic monitoring of vascular malformations. Design, Setting, and Participants: This pilot study examined 6 patients with arteriovenous malformation (AVM) and 6 patients with venous malformation (VM) diagnosed according to the classification system of the International Society for the Study of Vascular Anomalies. All patients underwent clinical hybrid MSOT/ultrasonographic (US) imaging before and after treatment at an interdisciplinary vascular malformations clinic by trained MSOT and US examiners. Examiners were blinded to the patient history and stage of disease. Data were collected from April 11 to 25, 2017, and analyzed from May 1 to October 31, 2017. Interventions: Clinical hybrid MSOT/US imaging was performed before or within 1 week after endovascular embolization (for AVM) or percutaneous sclerotherapy (for VM). Main Outcomes and Measures: Region-of-interest analysis of the lesion and contralateral healthy tissue revealed quantitative values for oxygenated (HbO2) and deoxygenated (HbR) hemoglobin by spectral unmixing of optoacoustic data acquired at multiple wavelengths. The HbO2:HbR ratio was calculated for healthy tissue and for AVM and VM before and after treatment. Results: Twelve patients (9 female and 3 male; mean [SD] age, 23 [18] years; age range, 6-59 years) with vascular malformations (6 with AVMs and 6 with VMs) were included. Significantly higher HbO2:HbR ratios for AVMs (mean [SEM], 1.82 [0.08] vs 0.89 [0.03]; P < .001) and for VMs (mean [SEM], 1.12 [0.04] vs 0.89 [0.03]; P = .001) were found on MSOT tissue compared with healthy tissue. Significantly higher HbO2:HbR ratios for AVMs compared with VMs (mean [SEM], 1.82 [0.08] vs 1.12 [0.04]; P < .001) were also found. Therefore, MSOT provided intrinsic biomarker patterns to distinguish both vascular malformations. After therapy, the HbO2:HbR ratio dropped in correlation to treatment success validated by magnetic resonance imaging or angiography. Conclusions and Relevance: This study suggests that different types of vascular malformations are clearly distinguished by MSOT-based, noninvasive assessment of hemoglobin levels in vascular malformations. The therapy effects found in this study could be instantly visualized, and this may offer a new tool for noninvasive diagnosis and monitoring of vascular malformations.
Asunto(s)
Hemoglobinas/análisis , Tomografía Óptica/métodos , Malformaciones Vasculares/diagnóstico , Adolescente , Adulto , Biomarcadores/sangre , Niño , Estudios Transversales , Diagnóstico Diferencial , Embolización Terapéutica/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Reproducibilidad de los Resultados , Escleroterapia/métodos , Malformaciones Vasculares/sangre , Malformaciones Vasculares/terapia , Adulto JovenRESUMEN
Vascular malformations enlarge overtime, particularly during adolescence when follicle-stimulating hormone (FSH) rises. Lesions contain the receptor for follicle-stimulating hormone. FSH also becomes elevated during menopause. We present a patient with a venous malformation of the lip that presented for the first time after she entered menopause which was temporally related to a significant increase in her serum FSH levels that were measured. This observation supports the hypothesis that FSH might influence the pathophysiology of vascular malformations.
Asunto(s)
Hormona Folículo Estimulante/sangre , Menopausia/sangre , Malformaciones Vasculares/sangre , Malformaciones Vasculares/patología , Femenino , Humanos , Labio , Persona de Mediana EdadAsunto(s)
Bronquiolitis/etiología , Cianosis/diagnóstico por imagen , Conducto Arterioso Permeable/cirugía , Síndrome Hepatopulmonar/diagnóstico por imagen , Vena Porta/anomalías , Malformaciones Vasculares/diagnóstico , Bronquiolitis/sangre , Bronquiolitis/diagnóstico por imagen , Cateterismo Cardíaco , Preescolar , Cianosis/sangre , Cianosis/etiología , Conducto Arterioso Permeable/diagnóstico por imagen , Síndrome Hepatopulmonar/sangre , Síndrome Hepatopulmonar/etiología , Humanos , Hiperamonemia/etiología , Masculino , Tomografía Computarizada por Rayos X , Ultrasonografía/métodos , Malformaciones Vasculares/sangre , Malformaciones Vasculares/complicacionesRESUMEN
The quality standards of the French Society of Vascular Medicine for the ultrasonographic assessment of vascular malformations are based on the two following requirements: (1) technical know-how: mastering the use of ultrasound devices and the method of examination; (2) medical know-how: ability to adapt the methods and scope of the examination to its clinical indication and purpose, and to rationally analyze and interpret its results. AIMS OF THE QUALITY STANDARDS: To describe an optimal method of examination in relation to the clinical question and hypothesis. To homogenize practice, methods, glossary, and reporting. To provide good practice reference points, and promote a quality process. ITEMS OF THE QUALITY STANDARDS: The 3 levels of examination; their clinical indications and goals. The reference standard examination (level 2), its variants according to clinical needs. The minimal content of the examination report; the letter to the referring physician (synthesis, conclusion and proposal for further investigation and/or therapeutic management). Commented glossary (anatomy, hemodynamics, semiology). Technical bases. Setting and use of ultrasound devices. Here, we discuss ultrasonography methods of using of ultrasonography for the assessment of peripheral vascular malformations and tumors (limbs, face, trunk).
Asunto(s)
Ultrasonografía Doppler Dúplex/normas , Malformaciones Vasculares/diagnóstico por imagen , Neoplasias Vasculares/diagnóstico por imagen , Adulto , Trastornos de la Coagulación Sanguínea/sangre , Trastornos de la Coagulación Sanguínea/etiología , Velocidad del Flujo Sanguíneo , Competencia Clínica , Progresión de la Enfermedad , Neoplasias del Ojo/diagnóstico por imagen , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Fibrinógeno/análisis , Hemangioma/diagnóstico por imagen , Hemodinámica , Humanos , Lactante , Linfangioma Quístico/diagnóstico por imagen , Masculino , Garantía de la Calidad de Atención de Salud , Ultrasonografía Doppler en Color/instrumentación , Ultrasonografía Doppler en Color/métodos , Ultrasonografía Doppler Dúplex/instrumentación , Ultrasonografía Doppler Dúplex/métodos , Malformaciones Vasculares/sangre , Malformaciones Vasculares/clasificación , Malformaciones Vasculares/complicacionesRESUMEN
Few preliminary reports studied the utility of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) for differentiation between infantile hemangiomas (IHs) and vascular malformations. The aim of this study was to investigate the role of serum VEGF and bFGF levels in differentiating IHs from vascular malformations and identifying the stage and clinical course of IHs. Serum levels of VEGF and bFGF were assessed in 60 infants and children with various cutaneous vascular anomalies defined in 3 groups: proliferating IHs (n = 25), involuting IHs (n = 23), and vascular malformations (n = 12), in comparison with their levels in 40 healthy matched control. Serum levels of VEGF and bFGF were significantly elevated in all groups as compared to control ( P < .001, respectively). Both proliferating and involuting IHs had comparable levels of both markers ( P > .05, respectively) that were significantly higher in comparison with vascular malformations ( P < .05, respectively). Significantly lower VEGF levels were found in IHs that had regressed spontaneously (n = 11) compared to those regressed by treatment (n = 37), ( P < .05); meanwhile, bFGF showed no significant difference between both groups ( P > .05). Using receiver operating characteristic curves, a combined use of VGEF and bFGF yielded a sensitivity of 85.42% and a specificity of 100% for differentiating IHs from vascular malformations. Serum VEGF and/or bFGF levels are increased in cutaneous vascular anomalies and can differentiate IHs from vascular malformations. None of these markers could help in identifying the stage of IHs. Low VEGF is associated with spontaneous regression of IHs.
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/sangre , Factor A de Crecimiento Endotelial Vascular/sangre , Malformaciones Vasculares/sangre , Adolescente , Adulto , Estudios de Casos y Controles , Niño , Estudios Transversales , Femenino , Hemangioma , Humanos , Masculino , Adulto JovenRESUMEN
INTRODUCTION: Venous malformations (VMs) are ubiquitous, low-flow vascular anomalies known to be occasionally painful due to thrombotic episodes within the lesion. The prevalence of superficial or deep vein thrombosis is unclear. METHODS: A cross-sectional study among outpatients aged ≥ 12 years with pure VMs was performed, quantifying the prevalence of thrombosis by screening all patients with compression ultrasonography (CUS). Additionally, we evaluated whether coagulation alterations were related to thrombosis observed with CUS. RESULTS: In total, 69 patients with pure VMs were eligible, median age was 30 years (range 12-63) and 52% were female. A total of 68 patients underwent CUS. Superficial vein thrombosis was observed in 10 (15%) cases; 1 patient had a current asymptomatic deep venous thrombosis. Residual superficial or deep thrombosis was observed in 25 patients (36%). In total, 49% had either a history or current signs of a thrombotic event and overall 10% had venous thromboembolism. In approximately 50% of the patients the D-dimer level was above 0.5 mg/l. Median P-selectin and Von Willebrand factor levels were 29 ng/ml (interquartile range (IQR) 21-34) and 108% (IQR 83-132), respectively. No differences were observed in the coagulation parameters between the patients with and without current clots in their VM. CONCLUSION: This study shows that superficial or deep vein thrombosis is common among patients with a pure VM. Physicians should be aware of this high incidence, especially if other risk factors for thrombosis are present.
Asunto(s)
Factores de Coagulación Sanguínea/análisis , Coagulación Sanguínea , Malformaciones Vasculares/complicaciones , Trombosis de la Vena/etiología , Adolescente , Adulto , Niño , Estudios Transversales , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Humanos , Masculino , Persona de Mediana Edad , Ultrasonografía , Malformaciones Vasculares/sangre , Trombosis de la Vena/diagnóstico por imagen , Trombosis de la Vena/epidemiología , Adulto JovenRESUMEN
OBJECTIVE To compare ammonia concentrations in arterial blood, venous blood, and CSF samples of dogs with and without extrahepatic portosystemic shunts (EHPSS). ANIMALS 19 dogs with congenital EHPSS and 6 healthy control dogs. PROCEDURES All dogs underwent a physical examination and then were anesthetized for transsplenic portal scintigraphy to confirm the presence or absence of EHPSS. While dogs were anesthetized, arterial and venous blood samples and a CSF sample were simultaneously collected for determination of ammonia concentration, which was measured by use of a portable blood ammonia analyzer (device A) and a nonportable biochemical analyzer (device B). Results were compared between dogs with EHPSS and control dogs. RESULTS Arterial, venous, and CSF ammonia concentrations for dogs with EHPSS were significantly greater than those for control dogs. For dogs with EHPSS, ammonia concentrations in both arterial and venous blood samples were markedly increased from the reference range. There was a strong positive correlation between arterial and venous ammonia concentrations and between blood (arterial or venous) and CSF ammonia concentrations. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that blood and CSF ammonia concentrations in dogs with EHPSS were greater than those for healthy dogs and were strongly and positively correlated, albeit in a nonlinear manner. This suggested that the permeability of the blood-brain barrier to ammonia may be abnormally increased in dogs with EHPSS, but further investigation of the relationship between blood or CSF ammonia concentration and clinical signs of hepatic encephalopathy or the surgical outcome for dogs with EHPSS is warranted.
Asunto(s)
Amoníaco/sangre , Amoníaco/líquido cefalorraquídeo , Enfermedades de los Perros/sangre , Enfermedades de los Perros/líquido cefalorraquídeo , Vena Porta/anomalías , Malformaciones Vasculares/veterinaria , Animales , Arterias , Barrera Hematoencefálica , Perros , Femenino , Encefalopatía Hepática/veterinaria , Masculino , Malformaciones Vasculares/sangre , Malformaciones Vasculares/líquido cefalorraquídeo , VenasRESUMEN
Hepatic encephalopathy (HE) remains a diagnosis of exclusion due to the lack of specific signs and symptoms. Refractory HE is an uncommon but serious condition that requires the search of hidden precipitating events (i.e., portosystemic shunt) and alternative diagnosis. Hypothyroidism shares clinical manifestations with HE and is usually considered within the differential diagnosis of HE. Here, we describe a patient with refractory HE who presented a large portosystemic shunt and post-ablative hypothyroidism. Her cognitive impairment, hyperammonaemia, electroencephalograph alterations, impaired neuropsychological performance, and magnetic resonance imaging and spectroscopy disturbances were highly suggestive of HE, paralleled the course of hypothyroidism and normalized after thyroid hormone replacement. There was no need for intervention over the portosystemic shunt. The case findings support that hypothyroidism may precipitate HE in cirrhotic patients by inducing hyperammonaemia and/or enhancing ammonia brain toxicity. This case led us to consider hypothyroidism not only in the differential diagnosis but also as a precipitating factor of HE.
Asunto(s)
Amoníaco/metabolismo , Resistencia a Medicamentos , Encefalopatía Hepática/tratamiento farmacológico , Hiperamonemia/sangre , Hipotiroidismo/metabolismo , Cirrosis Hepática Alcohólica/complicaciones , Antagonistas Adrenérgicos beta/uso terapéutico , Alcoholismo/complicaciones , Amoníaco/sangre , Antitiroideos/uso terapéutico , Encéfalo/diagnóstico por imagen , Carbimazol/uso terapéutico , Diagnóstico Diferencial , Trastornos de Somnolencia Excesiva/sangre , Trastornos de Somnolencia Excesiva/diagnóstico por imagen , Trastornos de Somnolencia Excesiva/etiología , Disartria/sangre , Disartria/diagnóstico por imagen , Disartria/etiología , Electroencefalografía , Embolización Terapéutica , Femenino , Bocio Nodular/sangre , Bocio Nodular/complicaciones , Bocio Nodular/tratamiento farmacológico , Bocio Nodular/metabolismo , Encefalopatía Hepática/sangre , Encefalopatía Hepática/diagnóstico , Encefalopatía Hepática/metabolismo , Humanos , Hiperamonemia/complicaciones , Hipotiroidismo/sangre , Hipotiroidismo/diagnóstico , Hipotiroidismo/tratamiento farmacológico , Cirrosis Hepática Alcohólica/sangre , Imagen por Resonancia Magnética , Persona de Mediana Edad , Vena Porta/anomalías , Vena Porta/diagnóstico por imagen , Derivación Portosistémica Intrahepática Transyugular , Propranolol/uso terapéutico , Venas Renales/anomalías , Venas Renales/diagnóstico por imagen , Tirotropina/sangre , Tiroxina/uso terapéutico , Tomografía Computarizada por Rayos X , Malformaciones Vasculares/sangre , Malformaciones Vasculares/complicaciones , Malformaciones Vasculares/terapiaRESUMEN
BACKGROUND AND OBJECTIVES: Thrombosis is an uncommon disorder in children. Patients with slowflow vascular malformations have higher risk of developing localized intravascular coagulation, which is closely related to the presence of thrombotic events. These episodes cause pain, can be recurrent and determine a clear deterioration in the quality of life. Moreover, serious complications such as pulmonary thromboembolism and eventually death have been described. The aim of the present study is to identify clinical and laboratory risk factors associated with thrombotic events in pediatric patients with vascular malformations. METHODS: Case-Control study. Clinical records of patients who consulted the vascular anomalies study group (VASG). This group carries out interdisciplinary assessment of patients with vascular malformations. From June 2008 to December 2014, 110 patients were assessed of whom 46 patients met the inclusion criteria, with half of them presenting a thrombotic complication and the others not, these latter serving as controls. Statistical analysis included multivariate logistic regression analysis to determine major risk factors for thrombosis. RESULTS: In the bivariate analysis we found a significant association between increased levels of Ddimer and thrombotic complications (OR 17.1 [95% CI 3.95-73.95; p<0.01]). In addition, a surface area≥10cm2 (OR 6.18 [95% CI 1.59-23.99; p<0.01]) and the presence of palpable phleboliths (OR 20.17 [95% CI 2.32-165.77; p<0.01]) were associated with a significant higher risk of thrombosis. Multivariate analysis identified older age (OR 1.33; p=0.013), a surface area≥10cm2 (OR 8.19; p=0.042) and palpable phleboliths (OR 85.29; p<0.01) as significant risk factors. CONCLUSIONS: Our study suggests the existence of clinical factors associated with higher risk of thrombotic complications, such as the extent of the malformation, palpable phleboliths and increased age among children with vascular malformations.
Asunto(s)
Trombosis/etiología , Malformaciones Vasculares/complicaciones , Adolescente , Factores de Edad , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Humanos , Lactante , Masculino , Análisis Multivariante , Embolia Pulmonar/etiología , Calidad de Vida , Factores de Riesgo , Malformaciones Vasculares/sangre , Malformaciones Vasculares/patologíaRESUMEN
Diffuse venous malformations can be associated with a consumptive coagulopathy characterized by a reduction of fibrinogen level, platelet count and elevated D-dimer level. We report a case of a patient with extensive venous malformations, hemorrhagic symptoms and biological signs of intravascular coagulopathy. She was initially treated effectively with low-molecular weight heparin (LMWH) (enoxaparin 1âmg/kg, bid) and switched to low-dose dabigatran etexilate (110âmg bid) for more than 2 years. Both treatments showed a similar clinical efficacy with the absence of bleeding or thrombotic complications. Compared with LMWH, dabigatran etexilate provided a similar correction of the fibrinogen level and platelet count but was less effective to reduce the D-dimer level. Although dabigatran etexilate can be safely used to control the consumptive coagulopathy secondary to venous malformation and provides a practical alternative to LMWH, its efficacy in vivo at a low dose to reduce the D-dimer level was lower than that of LMWH.
Asunto(s)
Anticoagulantes/uso terapéutico , Dabigatrán/uso terapéutico , Coagulación Intravascular Diseminada/tratamiento farmacológico , Enoxaparina/uso terapéutico , Trombosis/tratamiento farmacológico , Malformaciones Vasculares/tratamiento farmacológico , Adulto , Plaquetas/metabolismo , Plaquetas/patología , Coagulación Intravascular Diseminada/sangre , Coagulación Intravascular Diseminada/diagnóstico , Coagulación Intravascular Diseminada/etiología , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/metabolismo , Fibrinógeno/metabolismo , Humanos , Recuento de Plaquetas , Trombosis/sangre , Trombosis/complicaciones , Trombosis/diagnóstico , Malformaciones Vasculares/sangre , Malformaciones Vasculares/complicaciones , Malformaciones Vasculares/diagnósticoRESUMEN
No disponible
Asunto(s)
Adulto , Humanos , Masculino , Imagenología Tridimensional/instrumentación , Imagenología Tridimensional/métodos , Malformaciones Vasculares/sangre , Malformaciones Vasculares/genética , Neoplasias Cutáneas/congénito , Neoplasias Cutáneas/genética , Células Endoteliales/citología , Nevo/genética , Imagenología Tridimensional/normas , Imagenología Tridimensional , Malformaciones Vasculares/complicaciones , Malformaciones Vasculares/metabolismo , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología , Células Endoteliales/metabolismo , Nevo/patologíaRESUMEN
Congenital portosystemic shunt (CPSS) is persistence of an anomalous embryological connection of the portal vein with a large vein of the vena cava system. Clinical presentations include neonatal cholestasis, liver tumors, and encephalopathy, but can be variable in timing and symptomatology. We report 2 girls who presented 10 years apart with the same complaint of early pubarche at age 7 years, with inappropriately low DHEAS levels. In addition to hyperandrogenemia (elevated testosterone and androstenedione) and advanced bone age, both had hyperinsulinemia, and hypothyroxinemia. The 2nd case also had symptomatic hypoglycemia. Presentation of CPSS with this combination of findings in prepubertal children has not been reported previously. With further investigations, we proposed novel mechanisms explaining these manifestations. Hyperandrogenemia is caused by decreased hepatic sulfation of DHEA to less active DHEAS due to shunting of DHEA to systemic circulation. Elevated DHEA is then used for synthesis of more potent androgens. Shunting of postabsorbtive glucose from portal to systemic circulation causes early hyperglycemia leading to exaggerated insulin secretion. Insulin bypasses the hepatic metabolism directly entering into the systemic circulation, which results in hyperinsulinemia, then in turn causes late hypoglycemia. Finally, hypothyroxinemia was linked to thyroxin-binding globulin deficiency, which has not been reported in CPSS.
Asunto(s)
Hiperinsulinismo/etiología , Pubertad Precoz/etiología , Tiroxina/sangre , Malformaciones Vasculares/complicaciones , Adolescente , Niño , Femenino , Humanos , Hiperinsulinismo/sangre , Pubertad Precoz/sangre , Malformaciones Vasculares/sangreRESUMEN
BACKGROUND: Portosystemic shunts (PSS) are abnormal vascular connections between the portal vein or its tributaries and the systemic vein that allow mesenteric blood to reach the systemic circulation without first passing through the liver. PSS can be associated with various syndromes and can lead to serious complications. We report a rare case of a child with PSS and recurrent hypoglycaemia. CASE: A 20-month-old girl with Down's syndrome presented with recurrent hypoglycaemic episodes. She had multiple anomalies including a ventricular septal defect, oesophageal atresia and tracheo-esophageal fistula, gastro-oesophageal reflux, and conjugated hyperbilirubinaemia. The initial investigations suggested hyperinsulinaemic hypoglycaemia (HH). She did not respond to diazoxide. An oral glucose tolerance test suggested postprandial HH. Further vascular imaging showed a side-to-side portocaval shunt (Abernethy malformation) with relative hypoperfusion of the liver. Hypoglycaemia resolved following surgical closure of the portocaval shunt. CONCLUSION: PSS can rarely be associated with HH, possibly due to lack of insulin degradation in the liver. Surgical closure of the shunt resolves the hypoglycaemia.
Asunto(s)
Hiperinsulinismo , Hipoglucemia , Vena Porta/anomalías , Malformaciones Vasculares , Femenino , Humanos , Hiperinsulinismo/sangre , Hiperinsulinismo/diagnóstico por imagen , Hipoglucemia/sangre , Hipoglucemia/diagnóstico por imagen , Lactante , Vena Porta/diagnóstico por imagen , Radiografía , Malformaciones Vasculares/sangre , Malformaciones Vasculares/diagnóstico por imagenRESUMEN
Vascular anomalies are divided according to the contemporary system of classification into two groups: tumors and malformations. However, there is no consensus on juvenile angiofibroma's place in that system. The general characteristics of selected markers of angiogenesis and tissue remodeling are presented in the series in the context of current knowledge in the field of pathophysiology of vascular lesions. The mentioned markers are currently the subjects of multidirectional studies in oncology, as they take part in the process of neoangiogenesis and proliferation of tumors. Nevertheless, they have not been widely examined in vascular lesions. The indirect goal of that series is to indicate the possible research direction on vascular lesions to determine their molecular profile, to create a more specific system of classification, and above all to develop new diagnostic and treatment methods.
Asunto(s)
Angiofibroma/sangre , Angiofibroma/diagnóstico , Neoplasias de Cabeza y Cuello/sangre , Neoplasias de Cabeza y Cuello/diagnóstico , Hemangioma/sangre , Hemangioma/diagnóstico , Adolescente , Biomarcadores/sangre , Niño , Preescolar , Femenino , Cabeza/irrigación sanguínea , Humanos , Lactante , Recién Nacido , Masculino , Cuello/irrigación sanguínea , Neovascularización Patológica/patología , Malformaciones Vasculares/sangre , Malformaciones Vasculares/diagnóstico , Malformaciones Vasculares/fisiopatologíaRESUMEN
We report our success in employing LDLT as a course of treatment for extensive hepatic VM. A 14-yr-old pediatric patient presented at our hospital with nosebleed, fatigability, orthopnea, and abdominal distension. He had a history of right hemicolectomy with primary anastomosis due to VM of the transverse colon at age seven. Coagulation abnormalities were apparent, characterized by high international normalized ratio of prothrombin time, decreased fibrinogen level, increased FDPs, and D-dimer. T2-weighted magnetic resonance imaging revealed numerous, variable-sized high signal intensity nodules. Abdominal ultrasonography and CT scan showed hepatomegaly with multiple hypo-echogenic lesions and arteriovenous shunting in the liver. Doppler ultrasound showed hypokinetic flow in the hypo-echogenic lesions of liver. Immediate LDLT was performed to avoid spontaneous rupture and DIC. The right lobe of the liver was implanted with temporary portocaval shunt to prevent intestinal congestion and bleeding. Pathologic examination of the explanted liver confirmed the presence of an extensive hepatic VM. The postoperative course was uneventful, and the patient remained symptom-free with normal liver function throughout the 12-month follow-up period.